Variant report

Variant	nsv970333
Chromosome Location	chr6:64215926-64234330
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:636)
CpG islands
(count:61)
Chromatin interactive
region (count:11)
LncRNA
region (count:4)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:636 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr6:64223735-64225173	HepG2	liver:	n/a	n/a
2	ARID3A	chr6:64225504-64227219	HepG2	liver:	n/a	n/a
3	ARID3A	chr6:64219700-64220553	HepG2	liver:	n/a	chr6:64219882-64219898
4	ARID3A	chr6:64229184-64229816	HepG2	liver:	n/a	n/a
5	ARID3A	chr6:64231214-64232937	HepG2	liver:	n/a	n/a
6	ATF2	chr6:64229066-64229832	GM12878	blood:	n/a	n/a
7	ATF2	chr6:64229092-64229693	GM12878	blood:	n/a	n/a
8	ATF3	chr6:64232280-64232687	A549	lung:	n/a	n/a
9	BATF	chr6:64229104-64229658	GM12878	blood:	n/a	n/a
10	BATF	chr6:64229096-64229665	GM12878	blood:	n/a	n/a
11	BCL11A	chr6:64229104-64229644	GM12878	blood:	n/a	chr6:64229569-64229578
12	BCL11A	chr6:64229113-64229623	GM12878	blood:	n/a	chr6:64229569-64229578
13	BCL3	chr6:64225902-64226630	A549	lung:	n/a	n/a
14	BCL3	chr6:64232270-64232918	A549	lung:	n/a	n/a
15	BCL3	chr6:64219904-64220505	A549	lung:	n/a	n/a
16	BCL3	chr6:64219965-64220372	A549	lung:	n/a	n/a
17	BCL3	chr6:64229087-64229600	GM12878	blood:	n/a	chr6:64229569-64229578
18	BCL3	chr6:64224221-64224872	A549	lung:	n/a	n/a
19	BCL3	chr6:64224268-64224757	A549	lung:	n/a	n/a
20	BCLAF1	chr6:64229000-64229682	GM12878	blood:	n/a	chr6:64229569-64229578
21	BHLHE40	chr6:64229089-64229622	GM12878	blood:	n/a	n/a
22	BHLHE40	chr6:64232559-64232990	HepG2	liver:	n/a	n/a
23	BHLHE40	chr6:64219659-64219827	GM12878	blood:	n/a	n/a
24	BHLHE40	chr6:64219709-64220532	HepG2	liver:	n/a	n/a
25	BHLHE40	chr6:64228499-64228679	GM12878	blood:	n/a	n/a
26	BHLHE40	chr6:64223915-64225019	HepG2	liver:	n/a	n/a
27	CBX3	chr6:64225926-64226948	HCT-116	colon:	n/a	n/a
28	CBX3	chr6:64225974-64226859	HCT-116	colon:	n/a	n/a
29	CEBPB	chr6:64229250-64229613	Hela-S3	cervix:	n/a	chr6:64229333-64229344
30	CEBPB	chr6:64227246-64227404	H1-hESC	embryonic stem cell:	n/a	n/a
31	CEBPB	chr6:64226011-64226445	HepG2	liver:	n/a	chr6:64226182-64226193
32	CEBPB	chr6:64227235-64227413	A549	lung:	n/a	n/a
33	CEBPB	chr6:64232940-64233154	Hela-S3	cervix:	n/a	n/a
34	CEBPB	chr6:64225947-64226778	ECC-1	luminal epithelium:	n/a	chr6:64226182-64226193
35	CEBPB	chr6:64223890-64224833	A549	lung:	n/a	chr6:64224023-64224034
36	CEBPB	chr6:64225985-64226821	ECC-1	luminal epithelium:	n/a	chr6:64226182-64226193
37	CEBPB	chr6:64223838-64225115	HepG2	liver:	n/a	chr6:64224023-64224034
38	CEBPB	chr6:64223911-64224353	HepG2	liver:	n/a	chr6:64224023-64224034
39	CEBPB	chr6:64226013-64226719	HepG2	liver:	n/a	chr6:64226182-64226193
40	CEBPB	chr6:64219950-64220373	HepG2	liver:	n/a	n/a
41	CEBPB	chr6:64224372-64224803	A549	lung:	n/a	n/a
42	CEBPB	chr6:64225928-64226607	A549	lung:	n/a	chr6:64226182-64226193
43	CEBPB	chr6:64225970-64226707	HepG2	liver:	n/a	chr6:64226182-64226193
44	CEBPB	chr6:64226000-64226769	Hela-S3	cervix:	n/a	chr6:64226182-64226193
45	CEBPB	chr6:64224831-64225097	HepG2	liver:	n/a	n/a
46	CEBPB	chr6:64229294-64229682	A549	lung:	n/a	chr6:64229333-64229344 chr6:64229609-64229622
47	CEBPB	chr6:64224465-64224775	HepG2	liver:	n/a	n/a
48	CEBPB	chr6:64232463-64232753	HepG2	liver:	n/a	n/a
49	CEBPB	chr6:64232169-64232791	A549	lung:	n/a	n/a
50	CEBPB	chr6:64225824-64226994	HCT-116	colon:	n/a	chr6:64226182-64226193

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:64226341-64226391	ProgFib	skin:	n/a
2	chr6:64226341-64226391	SAEC	small airway:	n/a
3	chr6:64226341-64226391	Jurkat	blood:	n/a
4	chr6:64226341-64226391	Hela-S3	cervix:	n/a
5	chr6:64226341-64226391	ovcar-3	ovarian:	n/a
6	chr6:64226341-64226391	HepG2	liver:	n/a
7	chr6:64226341-64226391	AG04450	lung:	fetal
8	chr6:64226341-64226391	AG04449	skin:	fetal
9	chr6:64226341-64226391	HRCEpiC	kidney:	n/a
10	chr6:64226341-64226391	HEK293	kidney:	embryo
11	chr6:64226341-64226391	HMEC	breast:	n/a
12	chr6:64226341-64226391	T-47D	breast:	n/a
13	chr6:64226341-64226391	GM12891	blood:	n/a
14	chr6:64226341-64226391	NT2-D1	testis:	n/a
15	chr6:64226341-64226391	HUVEC	blood vessel:	n/a
16	chr6:64226341-64226391	SK-N-MC	brain:	n/a
17	chr6:64226341-64226391	A549	lung:	n/a
18	chr6:64226341-64226391	MCF-7	breast:	n/a
19	chr6:64226341-64226391	SK-N-SH	brain:	n/a
20	chr6:64226341-64226391	HRPEpiC	eye:	n/a
21	chr6:64226341-64226391	HAEpiC	amniotic membrane:	n/a
22	chr6:64226341-64226391	ECC-1	luminal epithelium:	n/a
23	chr6:64226341-64226391	IMR90	lung:	fetal
24	chr6:64226341-64226391	BE2_C	brain:	n/a
25	chr6:64226341-64226391	SKMC	muscle:	n/a
26	chr6:64226341-64226391	HEEpiC	esophagus:	n/a
27	chr6:64226341-64226391	H1-hESC	embryonic stem cell:	embryo
28	chr6:64226341-64226391	HCF	heart:	n/a
29	chr6:64226341-64226391	PFSK-1	brain:	n/a
30	chr6:64226341-64226391	HNPCEpiC	eye:	n/a
31	chr6:64226341-64226391	AG10803	skin:	n/a
32	chr6:64226341-64226391	Caco-2	colon:	n/a
33	chr6:64226341-64226391	PANC-1	pancreas:	n/a
34	chr6:64226341-64226391	AG09309	skin:	n/a
35	chr6:64226341-64226391	HCT-116	colon:	n/a
36	chr6:64226341-64226391	GM06990	blood:	n/a
37	chr6:64226341-64226391	HIPEpiC	eye:	n/a
38	chr6:64226341-64226391	LNCaP	prostate:	n/a
39	chr6:64226341-64226391	NH-A	brain:	n/a
40	chr6:64226341-64226391	GM19239	blood:	n/a
41	chr6:64226341-64226391	NHBE	bronchial:	n/a
42	chr6:64226341-64226391	PrEC	prostate:	n/a
43	chr6:64226341-64226391	BJ	skin:	n/a
44	chr6:64226341-64226391	MCF10A-Er-Src	breast:	n/a
45	chr6:64226341-64226391	GM12878	blood:	n/a
46	chr6:64226341-64226391	GM12892	blood:	n/a
47	chr6:64226341-64226391	NHDF-neo	bronchial:	n/a
48	chr6:64226341-64226391	K562	blood:	n/a
49	chr6:64226341-64226391	HL-60	blood:	n/a
50	chr6:64226341-64226391	HCPEpiC	choroid plexus:	n/a

(count:11 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:64222475..64227668-chr6:64281290..64285637,7	MCF-7	breast:
2	chr6:64223038..64226107-chr6:64281300..64284743,4	MCF-7	breast:
3	chr6:64228157..64231841-chr6:64281826..64284222,3	MCF-7	breast:
4	chr6:64232277..64234216-chr6:64281288..64284127,4	MCF-7	breast:
5	chr6:64229449..64231298-chr6:64279012..64281297,2	MCF-7	breast:
6	chr6:64223459..64225605-chr6:64234001..64236545,2	K562	blood:
7	chr6:64232325..64242084-chr6:64281113..64285530,14	MCF-7	breast:
8	chr6:64215190..64216953-chr6:64279898..64282140,2	MCF-7	breast:
9	chr6:64223459..64225605-chr6:64234001..64236545,2	K562	blood:
10	chr6:64227477..64230312-chr6:64231567..64233558,2	MCF-7	breast:
11	chr6:64215756..64221142-chr6:64281924..64284707,6	MCF-7	breast:

(count:4 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-PTP4A1-2	chr6:64220677-64221246	NONHSAT113348
2	lnc-PTP4A1-2	chr6:64222146-64223644	NONHSAT113348
3	lnc-PTP4A1-2	chr6:64221566-64221674	NONHSAT113348
4	lnc-PTP4A1-2	chr6:64219602-64220586	NONHSAT113348

No data

Variant related genes	Relation type
PTP4A1	TF binding region
PTP4A1	CpG island
ENSG00000112245	chromatin interactions
ENSG00000266680	chromatin interactions

Extended variants
information (count: 658 )
Associated
traits (count: 77 )

Variant overlapped rSNPs/rCNVs (count:658 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs116608348	chr6:64215926-64215927	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs554455014	chr6:64215971-64215972	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs190555748	chr6:64215987-64215988	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs573451823	chr6:64216020-64216021	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs181866121	chr6:64216121-64216122	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs557499376	chr6:64216131-64216132	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs72880842	chr6:64216136-64216137	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs141252644	chr6:64216137-64216138	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs186074033	chr6:64216146-64216147	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs10943832	chr6:64216149-64216150	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	mRNA abundance
11	rs543752237	chr6:64216158-64216159	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs376472729	chr6:64216159-64216160	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs72482406	chr6:64216161-64216162	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs200387219	chr6:64216164-64216165	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs62412913	chr6:64216165-64216166	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs148343587	chr6:64216167-64216168	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs397833941	chr6:64216170-64216171	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs541144583	chr6:64216205-64216206	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs559158543	chr6:64216217-64216218	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs190249669	chr6:64216328-64216329	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs182519478	chr6:64216330-64216331	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs563198953	chr6:64216335-64216336	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs185365370	chr6:64216389-64216390	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs555279536	chr6:64216416-64216417	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs377081757	chr6:64216425-64216426	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs150048646	chr6:64216496-64216497	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs190668270	chr6:64216558-64216559	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs1744141	chr6:64216589-64216590	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
29	rs113131123	chr6:64216590-64216591	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs534741613	chr6:64216646-64216647	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs139448735	chr6:64216651-64216652	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs566289209	chr6:64216688-64216689	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs144077828	chr6:64216758-64216759	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs536811215	chr6:64216823-64216824	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs555304161	chr6:64216826-64216827	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs145011455	chr6:64216857-64216858	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs1681946	chr6:64216909-64216910	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
38	rs558955852	chr6:64216933-64216934	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs577154071	chr6:64216949-64216950	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs149046170	chr6:64216959-64216960	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs143082413	chr6:64216968-64216969	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs151179972	chr6:64216970-64216971	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs563577471	chr6:64216976-64216977	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs2622295	chr6:64216990-64216991	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs551781328	chr6:64217124-64217125	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs530785790	chr6:64217136-64217137	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs563135986	chr6:64217152-64217153	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs140090162	chr6:64217198-64217199	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs552168959	chr6:64217200-64217201	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs146938027	chr6:64217229-64217230	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:77)

Disease	PMID	Source
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	21448237	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Autism	22495311	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Gastric cancer	17908304	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Neuroblastoma	18923191	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	17603634	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Systemic lupus erythematosus	17503323	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Melanoma	18172304	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Cancer	21637783	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Colorectal cancer	16272173	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
T-cell lymphomas	19863542	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Lung cancer	18438408	CNVD
Follicular lymphoma	19010834	CNVD
Non-small cell lung cancer	21044232	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21385341	CNVD
Prostate cancer	16705090	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Ependymoma	16718352	CNVD
High-proliferative meningiomas	17937814	CNVD
Intracranial tumor	16823260	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	21364760	CNVD
Acute lymphoblastic leukemia	18458336	CNVD
Cancer	20164920	CNVD
Prostate cancer	16573809	CNVD
Ovarian cancer	19835627	CNVD
Acute myeloid leukemia	20729466	CNVD
Myelofibrosis	22110671	CNVD
Cancer	21183584	CNVD
Glioblastoma multiforme	22286061	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Breast cancer	16272173	CNVD
Developmental delay	21147756	CNVD
small cell lung cancer	20016488	CNVD
Multiple myeloma	17550852	CNVD

Chromatin state (count:169 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:64212800-64219600	Weak transcription	Fetal Intestine Small	intestine
2	chr6:64214800-64218400	Enhancers	HepG2	liver
3	chr6:64215200-64216600	Weak transcription	A549	lung
4	chr6:64215200-64216600	Weak transcription	Hela-S3	cervix
5	chr6:64215200-64217400	Enhancers	GM12878-XiMat	blood
6	chr6:64215200-64219400	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
7	chr6:64215200-64219600	Weak transcription	Skeletal Muscle Female	skeletal muscle
8	chr6:64215600-64216000	Enhancers	Liver	Liver
9	chr6:64216000-64219000	Weak transcription	Liver	Liver
10	chr6:64216600-64217800	Enhancers	A549	lung
11	chr6:64216600-64218000	Enhancers	Hela-S3	cervix
12	chr6:64217400-64219400	Weak transcription	Rectal Mucosa Donor 29	rectum
13	chr6:64217400-64219600	Weak transcription	GM12878-XiMat	blood
14	chr6:64217800-64219600	Weak transcription	A549	lung
15	chr6:64218000-64219600	Weak transcription	Hela-S3	cervix
16	chr6:64218400-64218800	Weak transcription	HepG2	liver
17	chr6:64218800-64219600	Enhancers	HepG2	liver
18	chr6:64219000-64219600	Enhancers	Rectal Mucosa Donor 31	rectum
19	chr6:64219000-64220000	Enhancers	Liver	Liver
20	chr6:64219000-64221600	Enhancers	Fetal Intestine Large	intestine
21	chr6:64219200-64220400	Enhancers	Breast Myoepithelial Primary Cells	Breast
22	chr6:64219400-64219600	Enhancers	Rectal Mucosa Donor 29	rectum
23	chr6:64219400-64220200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
24	chr6:64219400-64220200	Enhancers	Fetal Lung	lung
25	chr6:64219600-64219800	Enhancers	A549	lung
26	chr6:64219600-64220000	Enhancers	Colonic Mucosa	Colon
27	chr6:64219600-64220000	Flanking Active TSS	Rectal Mucosa Donor 29	rectum
28	chr6:64219600-64220000	Flanking Active TSS	Rectal Mucosa Donor 31	rectum
29	chr6:64219600-64220000	Enhancers	Skeletal Muscle Female	skeletal muscle
30	chr6:64219600-64220000	Flanking Active TSS	HepG2	liver
31	chr6:64219600-64220200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
32	chr6:64219600-64220200	Enhancers	Duodenum Smooth Muscle	Duodenum
33	chr6:64219600-64220200	Enhancers	HMEC	breast
34	chr6:64219600-64220200	Enhancers	NHEK	skin
35	chr6:64219600-64220400	Enhancers	Adipose Nuclei	Adipose
36	chr6:64219600-64220400	Enhancers	Hela-S3	cervix
37	chr6:64219600-64220600	Enhancers	GM12878-XiMat	blood
38	chr6:64219600-64221000	Enhancers	Colon Smooth Muscle	Colon
39	chr6:64219600-64221200	Enhancers	Duodenum Mucosa	Duodenum
40	chr6:64219600-64221200	Enhancers	Fetal Intestine Small	intestine
41	chr6:64219600-64221200	Enhancers	Stomach Mucosa	stomach
42	chr6:64219800-64220200	Flanking Active TSS	A549	lung
43	chr6:64220000-64220200	Active TSS	Rectal Mucosa Donor 29	rectum
44	chr6:64220000-64220200	Flanking Active TSS	Skeletal Muscle Female	skeletal muscle
45	chr6:64220000-64220200	Enhancers	Small Intestine	intestine
46	chr6:64220000-64220400	Enhancers	iPS-15b Cell Line	embryonic stem cell
47	chr6:64220000-64220400	Weak transcription	Liver	Liver
48	chr6:64220000-64221000	Enhancers	Pancreas	Pancrea
49	chr6:64220000-64221000	Enhancers	Rectal Mucosa Donor 31	rectum
50	chr6:64220000-64224200	Enhancers	HepG2	liver

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links